A novel mitochondrial tRNAAla gene variant causes chronic progressive external ophthalmoplegia in a patient with Huntington disease

[1]  E. Riccio,et al.  Medication adherence in Fabry patients treated with migalastat: Real world experience , 2023, Molecular genetics and metabolism reports.

[2]  Robert W. Taylor,et al.  Mutations causing mitochondrial disease: What is new and what challenges remain? , 2015, Science.

[3]  Robert W. Taylor,et al.  Pathogenic mitochondrial mt-tRNAAla variants are uniquely associated with isolated myopathy , 2015, European Journal of Human Genetics.

[4]  J. Marcinkowski,et al.  Skeletal muscle pathology in Huntington's disease , 2014, Front. Physiol..

[5]  V. Pertegato,et al.  Assessment of mitochondrial respiratory chain enzymatic activities on tissues and cultured cells , 2012, Nature Protocols.

[6]  P. Reddy,et al.  Mutant huntingtin, abnormal mitochondrial dynamics, defective axonal transport of mitochondria, and selective synaptic degeneration in Huntington's disease. , 2012, Biochimica et biophysica acta.

[7]  Vishwanath T. Anekonda,et al.  Mutant huntingtin's interaction with mitochondrial protein Drp1 impairs mitochondrial biogenesis and causes defective axonal transport and synaptic degeneration in Huntington's disease. , 2012, Human molecular genetics.

[8]  J. Elson,et al.  A comparative analysis approach to determining the pathogenicity of mitochondrial tRNA mutations , 2011, Human mutation.

[9]  P. Hemachandra Reddy,et al.  Abnormal mitochondrial dynamics, mitochondrial loss and mutant huntingtin oligomers in Huntington's disease: implications for selective neuronal damage. , 2011, Human molecular genetics.

[10]  Ronghua Li,et al.  Maternally inherited hearing loss is associated with the novel mitochondrial tRNA Ser(UCN) 7505T>C mutation in a Han Chinese family. , 2010, Molecular genetics and metabolism.

[11]  M. Mancuso,et al.  Mitochondrial DNA sequence variation and neurodegeneration , 2008, Human Genomics.

[12]  Robert W. Taylor,et al.  The m.5650G>A mitochondrial tRNAAla mutation is pathogenic and causes a phenotype of pure myopathy , 2008, Neuromuscular Disorders.

[13]  J. Cooper,et al.  Clinical correlates of mitochondrial function in Huntington's disease muscle , 2007, Movement disorders : official journal of the Movement Disorder Society.

[14]  J. Schiefer,et al.  Myopathy as a first symptom of Huntington's disease in a Marathon runner , 2007, Movement disorders : official journal of the Movement Disorder Society.

[15]  Yaping Qian,et al.  The mitochondrial tRNA(Ala) T5628C variant may have a modifying role in the phenotypic manifestation of the 12S rRNA C1494T mutation in a large Chinese family with hearing loss. , 2007, Biochemical and biophysical research communications.

[16]  D. Turnbull,et al.  Pure myopathy associated with a novel mitochondrial tRNA gene mutation , 2006, Neurology.

[17]  Guido Davidzon,et al.  Mitochondrial DNA and disease , 2005, Annals of medicine.

[18]  Xiaoming Li,et al.  Biochemical characterization of the mitochondrial tRNASer(UCN) T7511C mutation associated with nonsyndromic deafness. , 2004, Nucleic acids research.

[19]  Massimo Zeviani,et al.  Mitochondrial disorders , 2003, Current opinion in neurology.

[20]  S. Dimauro,et al.  Clinical and genetic heterogeneity in progressive external ophthalmoplegia due to mutations in polymerase gamma. , 2003, Archives of neurology.

[21]  P. Tonin,et al.  A new mutation in the mitochondrial tRNAAla gene in a patient with ophthalmoplegia and dysphagia , 2001, Neuromuscular Disorders.

[22]  C. Broeckhoven,et al.  Mutation of POLG is associated with progressive external ophthalmoplegia characterized by mtDNA deletions , 2001, Nature Genetics.

[23]  G. Comi,et al.  Human mitochondrial DNA deletions associated with mutations in the gene encoding Twinkle, a phage T7 gene 4-like protein localized in mitochondria , 2001, Nature Genetics.

[24]  L. Peltonen,et al.  Role of adenine nucleotide translocator 1 in mtDNA maintenance. , 2000, Science.

[25]  J. Cummings,et al.  Huntington's disease. , 1997, The Psychiatric clinics of North America.

[26]  D. Turnbull,et al.  A novel mitochondrial tRNA isoleucine gene mutation causing chronic progressive external ophthalmoplegia , 1997, Neurology.

[27]  Hans Lehrach,et al.  Huntingtin-Encoded Polyglutamine Expansions Form Amyloid-like Protein Aggregates In Vitro and In Vivo , 1997, Cell.

[28]  Manish S. Shah,et al.  A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes , 1993, Cell.

[29]  H. C. Cook,et al.  Manual of Histological Techniques , 1984 .

[30]  Xiongwei Zhu,et al.  Mitochondrial importance in Alzheimer's, Huntington's and Parkinson's diseases. , 2012, Advances in experimental medicine and biology.

[31]  E. García-Arumí,et al.  A novel mutation in the mitochondrial tRNA(Ala) gene (m.5636T>C) in a patient with progressive external ophthalmoplegia. , 2011, Mitochondrion.

[32]  S. Skatchkov,et al.  Mitochondrial DNA damage is a hallmark of chemically induced and the R6/2 transgenic model of Huntington's disease. , 2009, DNA repair.

[33]  A. Andreu,et al.  Analysis of human mitochondrial DNA mutations. , 2003, Methods in molecular biology.